Analyst Price Targets — AIRS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 14, 2026 10:04 am | — | Leerink Partners | $4.50 | $4.66 | TheFly | AirSculpt Technologies price target raised to $4.50 from $3 at Leerink |
| November 11, 2025 9:49 am | Whit Mayo | Leerink Partners | $6.00 | $6.34 | StreetInsider | Airsculpt Technologies Inc. (AIRS) PT Raised to $6 at Leerink Partners |
| May 14, 2024 6:26 am | Whit Mayo | Leerink Partners | $5.00 | $4.67 | TheFly | AirSculpt Technologies downgraded to Market Perform from Outperform at Leerink |
| November 11, 2022 3:07 pm | Korinne Wolfmeyer | Piper Sandler | $4.00 | $3.28 | TheFly | Piper downgrades AirSculpt to Neutral, slashes target to $4 on weak visibility |
| August 24, 2022 7:47 am | — | Morgan Stanley | $11.00 | $9.81 | Benzinga | Morgan Stanley Maintains Equal-Weight on AirSculpt Technologies, Raises Price Target to $11 |
Latest News for AIRS
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AirSculpt Technologies, Inc. ("AirSculpt" or the "Company") (NASDAQ: AIRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
AirSculpt Technologies NASDAQ: AIRS is seeing stabilization in its core body-contouring business after several quarters of declines, while expanding services aimed at patients using GLP-1 weight-loss drugs, Chief Executive Officer Yogi Jashnani said at a Canaccord consumer conference.
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
AirSculpt Technologies NASDAQ: AIRS reported second-quarter revenue of $42.9 million, down 2.5% from the prior-year period, as the company cited stable revenue trends, positive same-center case growth and continued investment in marketing and expanded procedure offerings.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AIRS.
U.S. House Trading
No House trades found for AIRS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.